Vici was founded by Dr. Anish Dhanarajan, PhD and Francesca Minale, M.Eng in 2016 with the goal of becoming a world class pharmaceutical product development company. Vici works hard at identifying unmet pharmaceutical needs that can be solved by drug development through the NDA 505(b)(2) or ANDA pathway. In pursuit of this goal, Vici operates a rapid, low-cost, high quality prototyping R&D facility capable of GMP operations in Maryland USA.
Working with CROs, third party testing labs, experienced consultants, manufacturing plants, and marketing partners, Vici is able to deliver and manage entire development programs. Vici is engages in product out-licensing and contract development.
What We Do
We are experts at formulation development, analytical method development, manufacturing process development and tech transfer, CRO management for BE studies, CMC regulatory documentation, and regulatory filings.